Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Carbohydrate-hydrolyzing enzymes are a broad class of enzymes that catalyze the hydrolysis of glycosidic bonds within complex carbohydrates, converting them into simpler sugars such as monosaccharides. They belong primarily to the hydrolases class under EC 3, specifically classified as glycoside hydrolases under EC 3.2.1[1][2][4]. These enzymes include amylases, maltases, sucrases, lactases, cellulases, chitinases, among others; each acts on specific substrates within dietary or structural polysaccharides[5]. Their main biological role is in digestion—breaking down starches and other complex sugars so they can be absorbed by organisms—and they also participate in various metabolic pathways involving carbohydrate turnover and remodeling[6]. The term "carbohydrate-hydrolyzing enzyme" is generic rather than a single molecular entity; it encompasses many distinct proteins with different substrate specificities but similar catalytic mechanisms—namely using water molecules to cleave glycosidic linkages via acid/base catalysis involving key amino acid residues at their active sites[6]. Because this designation refers collectively to a large family rather than an individual target molecule/receptor with a unique sequence or structure—and because therapeutic targeting typically focuses on specific members like "alpha-glucosidase" or "beta-galactosidase"—the entry is considered too broad/vague for precise drug discovery purposes. For structured data extraction or drug development applications requiring specificity at the gene/protein level ("canonical form"), it would be necessary to specify which particular carbohydrase/glycoside hydrolase is intended—for example "Alpha-glucosidase," "Beta-galactosidase," etc.—rather than use this umbrella term. Therefore: is_incorrect: true — The target name is too generic; more specificity is needed for structured annotation suitable for research/drug development contexts.
Competitive inhibition of the active site to block hydrolysis of dietary carbohydrates, delaying glucose absorption and blunting postprandial blood sugar rise.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Carbohydrate-hydrolyzing enzyme.